2024 Global Immunodiagnostics Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Clinical Chemistry, Drugs of Abuse, Endocrine Function, Immunoproteins, Special Chemistry, Therapeutic Drug Monitoring (TDM), Tumor Markers
LeadingMarketResearch.com new report is a strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations. The report explores future trends in the U.S., Europe and Asia; provides specimen, test and sales forecast; estimates sales and market shares of major suppliers; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities for reagent and instrument suppliers.
Rationale
Clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.
Geographic Coverage
Centralized Testing
%li%Ambulatory Care Centers
%li%Birth Centers
%li%nbsp;Cancer Clinics
%li% Emergency Departments
%li%ICUs/CCUs
%li% Nursing Homes
%li% Operating Recovery Suites
%li% Physician Offices/Group Practices
%li% Surgery Centers
Home/Self Testing
Test Categories
Routine Clinical Chemistry
Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total, BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus, Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid.
Therapeutic Drug Monitoring (TDM)
Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin.
Endocrine Function
Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab, TSH.
Tumor Markers and Special Chemistry
AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid), Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood, PAP, PSA, Thyroglobulin, Vitamin B-12.
Immunoproteins
C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM, Immunofixation, Prealbumin, Protein Electrophoresis.
Drugs of Abuse
Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic Antidepressants.
Current and Emerging Products
Rationale
Clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.
Geographic Coverage
- Europe
- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA
- Estimates of facilities performing clinical chemistry and immunodiagnostic tests by country.
- Test volume and sales projections by country.
- Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers, by country.
- Test volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays, by country and market segment:
Centralized Testing
- Hospitals
- Commercial/Private Laboratories
%li%Ambulatory Care Centers
%li%Birth Centers
%li%nbsp;Cancer Clinics
%li% Emergency Departments
%li%ICUs/CCUs
%li% Nursing Homes
%li% Operating Recovery Suites
%li% Physician Offices/Group Practices
%li% Surgery Centers
Home/Self Testing
Test Categories
- Clinical Chemistry
- Therapeutic Drug Monitoring
- Endocrine Function
- Drugs of Abuse
- Immunoproteins
- Tumor Markers and Special Chemistry
Routine Clinical Chemistry
Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total, BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus, Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid.
Therapeutic Drug Monitoring (TDM)
Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin.
Endocrine Function
Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab, TSH.
Tumor Markers and Special Chemistry
AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid), Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood, PAP, PSA, Thyroglobulin, Vitamin B-12.
Immunoproteins
C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM, Immunofixation, Prealbumin, Protein Electrophoresis.
Drugs of Abuse
Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic Antidepressants.
Current and Emerging Products
- Analysis of current and emerging clinical chemistry and immunodiagnostic tests.
- Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.
- Assessment of current and emerging technologies, and their potential market applications.
- Comprehensive lists of companies developing or marketing new technologies and products by test.
- New product development opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D. The companies analyzed in the report include:
- Abbott Laboratories
- Agilent Technologies
- Beckman Coulter/Danaher
- bioMerieux
- Bio-Rad
- DiaSorin
- Eiken Chemical
- Fujirebio
- Grifols
- Instrumentation Laboratory/Werfen
- Kyowa Medex
- Ortho-Clinical Diagnostics
- PerkinElmer
- Quest Diagnostics
- Roche
- Siemens Healthineers
- Sysmex
- Thermo Fisher
- Tosoh
- Wako
I. Introduction
II. Worldwide Market Overview
1. BUSINESS ENVIRONMENT
2. MARKET STRUCTURE
3. MARKET SIZE AND GROWTH
III. Major Product Development Opportunities
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VII. Worldwide Market and Technology Overview
A. Major Routine Chemistry Tests
1. ALBUMIN
2. ALKALINE PHOSPHATASE
3. ALT/SGPT
4. AMMONIA
Table of Contents (continued)
5. AMYLASE
6. AST/SGOT
7. BILIRUBIN, TOTAL
8. BLOOD GASES
9. BLOOD UREA NITROGEN (BUN)
10. CALCIUM
11. CARDIO CRP
12. CHOLESTEROL
13. CHOLINESTERASE
14. CRP
15. CREATININE
16. ELECTROLYTES
a. Carbon Dioxide/Bicarbonate
b. Chloride
c. Potassium
d. Sodium
17. FERRITIN
18. FRUCTOSAMINE
19. GAMMA-GLUTAMYL TRANSPEPTIDASE (GGT)
20. GLUCOSE
21. HIGH DENSITY LIPOPROTEIN (HDL)
22. HOMOCYSTEINE
23. IRON
24. LACTATE DEHYDROGENASE (LDH)
25. MAGNESIUM
26. PHOSPHORUS
27. PROTEIN
28. TRIGLYCERIDES
29. URIC ACID
30. TROPONIN
B. Therapeutic Drug Monitoring (TDM)
1. OVERVIEW
2. CARBAMAZEPINE
3. CYCLOSPORIN
4. DIGOXIN
5. EVEROLIMUS
6. GENTAMICIN
7. LAMOTRIGINE/LAMICTAL
8. LEVETIRACETAM
9. LIDOCAINE
10. LITHIUM
11. NAPA/PROCAINAMIDE
12. PHENYTOIN
13. QUINIDINE
II. Worldwide Market Overview
1. BUSINESS ENVIRONMENT
2. MARKET STRUCTURE
3. MARKET SIZE AND GROWTH
III. Major Product Development Opportunities
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VII. Worldwide Market and Technology Overview
A. Major Routine Chemistry Tests
1. ALBUMIN
2. ALKALINE PHOSPHATASE
3. ALT/SGPT
4. AMMONIA
Table of Contents (continued)
5. AMYLASE
6. AST/SGOT
7. BILIRUBIN, TOTAL
8. BLOOD GASES
9. BLOOD UREA NITROGEN (BUN)
10. CALCIUM
11. CARDIO CRP
12. CHOLESTEROL
13. CHOLINESTERASE
14. CRP
15. CREATININE
16. ELECTROLYTES
a. Carbon Dioxide/Bicarbonate
b. Chloride
c. Potassium
d. Sodium
17. FERRITIN
18. FRUCTOSAMINE
19. GAMMA-GLUTAMYL TRANSPEPTIDASE (GGT)
20. GLUCOSE
21. HIGH DENSITY LIPOPROTEIN (HDL)
22. HOMOCYSTEINE
23. IRON
24. LACTATE DEHYDROGENASE (LDH)
25. MAGNESIUM
26. PHOSPHORUS
27. PROTEIN
28. TRIGLYCERIDES
29. URIC ACID
30. TROPONIN
B. Therapeutic Drug Monitoring (TDM)
1. OVERVIEW
2. CARBAMAZEPINE
3. CYCLOSPORIN
4. DIGOXIN
5. EVEROLIMUS
6. GENTAMICIN
7. LAMOTRIGINE/LAMICTAL
8. LEVETIRACETAM
9. LIDOCAINE
10. LITHIUM
11. NAPA/PROCAINAMIDE
12. PHENYTOIN
13. QUINIDINE
